Maciej is a Director based in London and Paris. He joined Bridgepoint in 2011 and is a member of the Technology investment team.

He currently sits on the board of Infinigate and Dr Gerard.

Since joining Bridgepoint, Maciej has worked on the acquisitions of Infront, Ponant, Smyk, Stroili (THOM Europe), Kyriba, Pharmazell, Infinigate and Vivacy.

Prior to this, he spent three years in the Financial Sponsors Group within investment banking at Bank of America Merrill Lynch in London. He is a graduate of ESCP-EAP, holds a MSc in Management from City University and a Diplom-Kaufmann.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.